Genotype and phenotype characteristics of RHO-associated retinitis pigmentosa in the Japanese population.


Journal

Japanese journal of ophthalmology
ISSN: 1613-2246
Titre abrégé: Jpn J Ophthalmol
Pays: Japan
ID NLM: 0044652

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 09 07 2022
accepted: 19 11 2022
pubmed: 18 1 2023
medline: 16 3 2023
entrez: 17 1 2023
Statut: ppublish

Résumé

To identify the genotypic and phenotypic characteristics of rhodopsin (RHO)-associated retinitis pigmentosa (RP) in the Japanese population. Cross-sectional, single-center study METHODS: The medical records of 1336 patients with RP who underwent genetic testing at our clinic between November 2008 and September 2021 were reviewed, and patients with RHO variants were included. The patients were divided into class A and class B to assess genotype-phenotype correlations based on previous reports. The clinical findings, including best-corrected visual acuity (BCVA), OCT parameters (ellipsoid zone [EZ] width and central retinal thickness [CRT]), and presence of macular degeneration, of the 2 groups were compared. The study included 28 patients diagnosed with RHO-associated RP (class A, 19; class B, 9). The BCVA was significantly worse in class A patients than in class B patients (P = 0.045). Superior EZ width was significantly shorter in class A than in class B patients (P = 0.016). Class A patients tended to have thinner CRT and shorter inferior EZ width than those of class B patients, although this difference was not significant. Macular degeneration was observed in 61.5% of class A and 12.5% of class B patients, demonstrating that macular degeneration can be a common complication in class A variants. Patients with class A variants presented with a severer form of RP than that of patients with class B variants in the Japanese population. These results suggest that the phenotype of RHO-associated RP is linked to the location of the variants and that such a genotype-phenotype correlation is less affected by ethnicities with different genetic backgrounds.

Identifiants

pubmed: 36648560
doi: 10.1007/s10384-023-00975-y
pii: 10.1007/s10384-023-00975-y
doi:

Substances chimiques

Rhodopsin 9009-81-8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

138-148

Informations de copyright

© 2023. Japanese Ophthalmological Society.

Références

Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368:1795–809.
pubmed: 17113430 doi: 10.1016/S0140-6736(06)69740-7
Garafalo AV, Cideciyan AV, Héon E, Sheplock R, Pearson A, Yu CWY, et al. Progress in treating inherited retinal diseases: early subretinal gene therapy clinical trials and candidates for future initiatives. Prog Retin Eye Res. 2020;77: 100827.
pubmed: 31899291 doi: 10.1016/j.preteyeres.2019.100827
Dryja TP, McGee TL, Reichel E, Hahn LB, Cowley GS, Yandell DW, et al. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature. 1990;343:364–6.
pubmed: 2137202 doi: 10.1038/343364a0
Cideciyan AV, Hood DC, Huang Y, Banin E, Li ZY, Stone EM, et al. Disease sequence from mutant rhodopsin allele to rod and cone photoreceptor degeneration in man. Proc Natl Acad Sci USA. 1998;95:7103–8.
pubmed: 9618546 pmcid: 22754 doi: 10.1073/pnas.95.12.7103
Iannaccone A, Man D, Waseem N, Jennings BJ, Ganapathiraju M, Gallaher K, et al. Retinitis pigmentosa associated with rhodopsin mutations: correlation between phenotypic variability and molecular effects. Vision Res. 2006;46:4556–67.
pubmed: 17014888 doi: 10.1016/j.visres.2006.08.018
Audo I, Manes G, Mohand-Saïd S, Friedrich A, Lancelot ME, Antonio A, et al. Spectrum of rhodopsin mutations in French autosomal dominant rod-cone dystrophy patients. Invest Ophthalmol Vis Sci. 2010;51:3687–700.
pubmed: 20164459 doi: 10.1167/iovs.09-4766
Jacobson SG, McGuigan DB III, Sumaroka A, Roman AJ, Gruzensky ML, Sheplok R, et al. Complexity of the class B phenotype in autosomal dominant retinitis pigmentosa due to rhodopsin mutations. Invest Ophthalmol Vis Sci. 2016;57:4847–58.
pubmed: 27654411 pmcid: 5032913 doi: 10.1167/iovs.16-19890
Athanasiou D, Aguila M, Bellingham J, Li W, McCulley C, Reeves PJ, et al. The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy. Prog Retin Eye Res. 2018;62:1–23.
pubmed: 29042326 doi: 10.1016/j.preteyeres.2017.10.002
Dryja TP, McGee TL, Hahn LB, Cowley GS, Olsson JE, Reichel E, et al. Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. N Engl J Med. 1990;323:1302–7.
pubmed: 2215617 doi: 10.1056/NEJM199011083231903
Chan WM, Yeung KY, Pang CP, Baum L, Lau TC, Kwok AK, et al. Rhodopsin mutations in Chinese patients with retinitis pigmentosa. Br J Ophthalmol. 2001;85:1046–8.
pubmed: 11520753 pmcid: 1724134 doi: 10.1136/bjo.85.9.1046
Ando Y, Ohmori M, Ohtake H, Ohtoko K, Toyama S, Usami R, et al. Mutation screening and haplotype analysis of the rhodopsin gene locus in Japanese patients with retinitis pigmentosa. Mol Vis. 2007;13:1038–44.
pubmed: 17653048 pmcid: 2776539
Wada Y, Tamai M. Molecular genetic analysis for Japanese patients with autosomal dominant retinitis pigmentosa. Article in Japanese. Nippon Ganka Gakkai Zasshi. 2003;107:687–94. (in Japanese)
Arai Y, Maeda A, Hirami Y, Ishigami C, Kosugi S, Mandai M, et al. Retinitis pigmentosa with EYS mutations is the most prevalent inherited retinal dystrophy in Japanese populations. J Ophthalmol. 2015;2015: 819760.
pubmed: 26161267 pmcid: 4487330 doi: 10.1155/2015/819760
Meng D, Ragi SD, Tsang SH. Therapy in rhodopsin-mediated autosomal dominant retinitis pigmentosa. Mol Ther. 2020;28:2139–49.
pubmed: 32882181 pmcid: 7545001 doi: 10.1016/j.ymthe.2020.08.012
Sudharsan R, Beltran WA. Progress in gene therapy for rhodopsin autosomal dominant retinitis pigmentosa. Adv Exp Med Biol. 2019;1185:113–8.
pubmed: 31884598 pmcid: 7217593 doi: 10.1007/978-3-030-27378-1_19
Katagiri S, Hayashi T, Akahori M, Itabashi T, Nishino J, Yoshitake K, et al. RHO mutations (p.W126L and p.A346P) in two Japanese families with autosomal dominant retinitis pigmentosa. J Ophthalmol. 2014;2014:210947.
Maeda A, Yoshida A, Kawai K, Arai Y, Akiba R, Inaba A, et al. Development of a molecular diagnostic test for retinitis pigmentosa in the Japanese population. Jpn J Ophthalmol. 2018;62:451–7.
pubmed: 29785639 doi: 10.1007/s10384-018-0601-x
Inaba A, Maeda A, Yoshida A, Kawai K, Hirami Y, Kurimoto Y, et al. Truncating variants contribute to hearing loss and severe retinopathy in USH2A-associated retinitis pigmentosa in Japanese patients. Int J Mol Sci. 2020;21:7817.
pubmed: 33105608 pmcid: 7659936 doi: 10.3390/ijms21217817
Oishi M, Oishi A, Gotoh N, Ogino K, Higasa K, Iida K, et al. Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing. Invest Ophthalmol Vis Sci. 2014;55:7369–75.
pubmed: 25324289 doi: 10.1167/iovs.14-15458
den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, et al. HGVS Recommendations for the description of sequence variants: 2016 Update. Hum Mutat. 2016;37:564–9.
doi: 10.1002/humu.22981
Cideciyan AV, Jacobson SG, Roman AJ, Sumaroka A, Wu V, Charng J, et al. Rod function deficit in retained photoreceptors of patients with class B Rhodopsin mutations. Sci Rep. 2020;10:12552.
pubmed: 32724127 pmcid: 7387454 doi: 10.1038/s41598-020-69456-3
Koyanagi Y, Ueno S, Ito Y, Kominami T, Komori S, Akiyama M, et al. Relationship between macular curvature and common causative genes of retinitis pigmentosa in Japanese patients. Invest Ophthalmol Vis Sci. 2020;61:6.
pubmed: 32749464 pmcid: 7441377 doi: 10.1167/iovs.61.10.6
McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, et al. ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol. 2015;130:1–12.
pubmed: 25502644 doi: 10.1007/s10633-014-9473-7
Sung CH, Makino C, Baylor D, Nathans J. A rhodopsin gene mutation responsible for autosomal dominant retinitis pigmentosa results in a protein that is defective in localization to the photoreceptor outer segment. J Neurosci. 1994;14:5818–33.
pubmed: 7523628 pmcid: 6576989 doi: 10.1523/JNEUROSCI.14-10-05818.1994
Tam BM, Moritz OL, Hurd LB, Papermaster DS. Identification of an outer segment targeting signal in the COOH terminus of rhodopsin using transgenic Xenopus laevis. J Cell Biol. 2000;151:1369–80.
pubmed: 11134067 pmcid: 2150681 doi: 10.1083/jcb.151.7.1369
Berson EL, Rosner B, Weigel-DiFranco C, Dryja TP, Sandberg MA. Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations. Invest Ophthalmol Vis Sci. 2002;43:3027–36.
pubmed: 12202526
Tam BM, Moritz OL. The role of rhodopsin glycosylation in protein folding, trafficking, and light-sensitive retinal degeneration. J Neurosci. 2009;29:15145–54.
pubmed: 19955366 pmcid: 6665958 doi: 10.1523/JNEUROSCI.4259-09.2009
White DA, Fritz JJ, Hauswirth WW, Kaushal S, Lewin AS. Increased sensitivity to light-induced damage in a mouse model of autosomal dominant retinal disease. Invest Ophthalmol Vis Sci. 2007;48:1942–51.
pubmed: 17460245 doi: 10.1167/iovs.06-1131
Heckenlively JR, Rodriguez JA, Daiger SP. Autosomal dominant sectoral retinitis pigmentosa: two families with transversion mutation in codon 23 of rhodopsin. Arch Ophthalmol. 1991;109:84–91.
pubmed: 1987955 doi: 10.1001/archopht.1991.01080010086038
Xiao T, Xu K, Zhang X, Xie Y, Li Y. Sector retinitis pigmentosa caused by mutations of the RHO gene. Eye. 2019;33:592–9.
pubmed: 30390055 doi: 10.1038/s41433-018-0264-3
Hwa J, Garriga P, Liu X, Khorana HG. Structure and function in rhodopsin: packing of the helices in the transmembrane domain and folding to a tertiary structure in the intradiscal domain are coupled. Proc Natl Acad Sci USA. 1997;94:10571–6.
pubmed: 9380676 pmcid: 23405 doi: 10.1073/pnas.94.20.10571
Stojanovic A, Hwang I, Khorana HG, Hwa J. Retinitis pigmentosa rhodopsin mutations L125R and A164V perturb critical interhelical interactions: new insights through compensatory mutations and crystal structure analysis. J Biol Chem. 2003;278:39020–8.
pubmed: 12871954 doi: 10.1074/jbc.M303625200
Hwa J, Reeves PJ, Klein-Seetharaman J, Davidson F, Khorana HG. Structure and function in rhodopsin: further elucidation of the role of the intradiscal cysteines, Cys-110, -185, and -187, in rhodopsin folding and function. Proc Natl Acad Sci USA. 1999;96:1932–5.
pubmed: 10051572 pmcid: 26714 doi: 10.1073/pnas.96.5.1932
Krebs MP, Holden DC, Joshi P, Clark CL, Lee AH, Kaushal S. Molecular mechanisms of rhodopsin retinitis pigmentosa and the efficacy of pharmacological rescue. J Mol Biol. 2010;395:1063–78.
pubmed: 19913029 doi: 10.1016/j.jmb.2009.11.015
Liang Y, Fotiadis D, Maeda T, Maeda A, Modzelewska A, Filipek S, et al. Rhodopsin signaling and organization in heterozygote rhodopsin knockout mice. J Biol Chem. 2004;279:48189–96.
pubmed: 15337746 doi: 10.1074/jbc.M408362200
Nicholson P, Yepiskoposyan H, Metze S, Zamudio OR, Kleinschmidt N, et al. Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors. Cell Mol Life Sci. 2010;67:677–700.
pubmed: 19859661 doi: 10.1007/s00018-009-0177-1
Roman-Sanchez R, Wensel TG, Wilson JH. Nonsense mutations in the rhodopsin gene that give rise to mild phenotypes trigger mRNA degradation in human cells by nonsense-mediated decay. Exp Eye Res. 2016;145:444–9.
pubmed: 26416182 doi: 10.1016/j.exer.2015.09.013
Rodriguez JA, Herrera CA, Birch DG, Daiger SP. A leucine to arginine amino acid substitution at codon 46 of rhodopsin is responsible for a severe form of autosomal dominant retinitis pigmentosa. Hum Mutat. 1993;2:205–13.
pubmed: 8364589 doi: 10.1002/humu.1380020309
Sohocki MM, Daiger SP, Bowne SJ, Rodriquez JA, Northrup H, Heckenlively JR, et al. Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies. Hum Mutat. 2001;17:42–51.
pubmed: 11139241 pmcid: 2585107 doi: 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K
Sullivan LS, Bowne SJ, Birch DG, Hughbanks-Wheaton D, Heckenlively JR, Lewis RA, et al. Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families. Invest Ophthalmol Vis Sci. 2006;47:3052–64.
pubmed: 16799052 doi: 10.1167/iovs.05-1443
Coussa RG, Basali D, Maeda A, DeBenedictis M, Traboulsi EI. Sector retinitis pigmentosa: report of ten cases and a review of the literature. Mol Vis. 2019;25:869–89.
pubmed: 31908405 pmcid: 6937219
Kranich H, Bartkowski S, Denton MJ, Krey S, Dickinson P, Duvigneau C, et al. Autosomal dominant “sector” retinitis pigmentosa due to a point mutation predicting an Asn-15-Ser substitution of rhodopsin. Hum Mol Genet. 1993;2:813–4.
pubmed: 8353500 doi: 10.1093/hmg/2.6.813
Sheffield VC, Fishman GA, Beck JS, Kimura AE, Stone EM. Identification of novel rhodopsin mutations associated with retinitis pigmentosa by GC-clamped denaturing gradient gel electrophoresis. Am J Hum Genet. 1991;49:699–706.
pubmed: 1897520 pmcid: 1683182
Sung CH, Davenport CM, Hennessey JC, Maumenee IH, Jacobson SG, Heckenlively JR, et al. Rhodopsin mutations in autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci USA. 1991;88:6481–5.
pubmed: 1862076 pmcid: 52109 doi: 10.1073/pnas.88.15.6481
Fuchs S, Kranich H, Denton MJ, Zrenner E, Bhattacharya SS, Humphries P, et al. Three novel rhodopsin mutations (C110F, L131P, A164V) in patients with autosomal dominant retinitis pigmentosa. Hum Mol Genet. 1994;3:1203.
pubmed: 7981701 doi: 10.1093/hmg/3.7.1203
Dryja TP, Hahn LB, Cowley GS, McGee TL, Berson EL. Mutation spectrum of the rhodopsin gene among patients with autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci USA. 1991;88:9370–4.
pubmed: 1833777 pmcid: 52716 doi: 10.1073/pnas.88.20.9370
Richards JE, Scott KM, Sieving PA. Disruption of conserved rhodopsin disulfide bond by Cys187Tyr mutation causes early and severe autosomal dominant retinitis pigmentosa. Ophthalmology. 1995;102:669–77.
pubmed: 7724183 doi: 10.1016/S0161-6420(95)30972-4
al-Maghtheh M, Gregory C, Inglehearn C, Hardcastle A, Bhattacharya S. Rhodopsin mutations in autosomal dominant retinitis pigmentosa. Hum Mutat. 1993;2:249–55.

Auteurs

Daiki Sakai (D)

Department of Ophthalmology, Kobe City Eye Hospital, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan. dsakai1027@gmail.com.
Department of Ophthalmology, Kobe City Medical Center General Hospital, Kobe, Japan. dsakai1027@gmail.com.
Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, Japan. dsakai1027@gmail.com.

Masakazu Hiraoka (M)

Department of Ophthalmology, Kobe City Eye Hospital, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan.
Department of Ophthalmology, Kawasaki Medical School, Kurashiki, Okayama, Japan.

Mitsuhiro Matsuzaki (M)

Department of Ophthalmology, Kobe City Eye Hospital, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan.
Department of Ophthalmology, Kobe City Medical Center General Hospital, Kobe, Japan.

Satoshi Yokota (S)

Department of Ophthalmology, Kobe City Eye Hospital, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan.
Department of Ophthalmology, Kobe City Medical Center General Hospital, Kobe, Japan.

Yasuhiko Hirami (Y)

Department of Ophthalmology, Kobe City Eye Hospital, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan.
Department of Ophthalmology, Kobe City Medical Center General Hospital, Kobe, Japan.

Akishi Onishi (A)

Department of Ophthalmology, Kobe City Eye Hospital, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan.
Vision Care Inc., Kobe, Japan.

Makoto Nakamura (M)

Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, Japan.

Masayo Takahashi (M)

Department of Ophthalmology, Kobe City Eye Hospital, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan.
Vision Care Inc., Kobe, Japan.

Yasuo Kurimoto (Y)

Department of Ophthalmology, Kobe City Eye Hospital, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan.
Department of Ophthalmology, Kobe City Medical Center General Hospital, Kobe, Japan.

Akiko Maeda (A)

Department of Ophthalmology, Kobe City Eye Hospital, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan.
Department of Ophthalmology, Kobe City Medical Center General Hospital, Kobe, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH